Minerva Neurosciences (NERV) EPS (Diluted) (2019 - 2026)

Minerva Neurosciences (NERV) EPS (Diluted) (2019 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Diluted) (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 0.00
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 0.15
4 NuCana 279.75 Bn 279.75 Bn - -368,323.02
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 4.02
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 6.75
7 Belite Bio 62.51 Bn 62.51 Bn - 0.00
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 7.33
9 Revolution Medicines 37.78 Bn 37.78 Bn - -2.29
10 Minerva Neurosciences 195.10 Mn 195.10 Mn - -0.74

Historic Data

Download Data
DateValue
Mar 31, 2026 -0.74
Dec 31, 2025 -0.67
Sep 30, 2025 -0.36
Jun 30, 2025 -0.43
Mar 31, 2025 -0.49
Dec 31, 2024 -0.57
Sep 30, 2024 -0.54
Jun 30, 2024 -0.78
Mar 31, 2024 -0.84
Dec 31, 2023 -15.94
Sep 30, 2023 -0.89
Jun 30, 2023 -1.12
Mar 31, 2023 -0.93
Dec 31, 2022 -17.77
Sep 30, 2022 -1.06
Jun 30, 2022 -1.29
Mar 31, 2022 -1.51
Dec 31, 2021 -4.00
Sep 30, 2021 -1.44
Jun 30, 2021 -1.68